Armata Pharmaceuticals (ARMP) EBT Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -148.52% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 71.54% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -8.15% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -79.57% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 9,460.35% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -21.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.63% |
| Dec 31, 2025 | -35.01% |
| Sep 30, 2025 | 4.39% |
| Jun 30, 2025 | 26.08% |
| Mar 31, 2025 | 1.69% |
| Dec 31, 2024 | -26.07% |
| Sep 30, 2024 | -10.59% |
| Jun 30, 2024 | -50.38% |
| Mar 31, 2024 | -5.90% |
| Dec 31, 2023 | -6.27% |
| Sep 30, 2023 | -33.10% |
| Jun 30, 2023 | -3.99% |
| Mar 31, 2023 | -29.11% |
| Dec 31, 2022 | -70.56% |
| Sep 30, 2022 | -40.18% |
| Jun 30, 2022 | -48.77% |
| Mar 31, 2022 | -59.67% |
| Dec 31, 2021 | 7.72% |
| Sep 30, 2021 | -6.52% |
| Jun 30, 2021 | -31.51% |
| Mar 31, 2021 | -8.21% |
| Dec 31, 2020 | -42.89% |
| Sep 30, 2020 | 17.05% |
| Jun 30, 2020 | -12.17% |
| Mar 31, 2020 | -37.28% |
| Dec 31, 2019 | -316.53% |
| Sep 30, 2019 | -150.99% |
| Jun 30, 2019 | -32.59% |
| Mar 31, 2019 | -21.08% |
| Dec 31, 2018 | -122.68% |
| Sep 30, 2018 | -255.71% |
| Jun 30, 2018 | 59.20% |
| Mar 31, 2018 | 9.08% |
| Dec 31, 2017 | 62.89% |
| Sep 30, 2017 | 67.20% |
| Jun 30, 2017 | -101.58% |
| Mar 31, 2017 | 25.63% |
| Dec 31, 2016 | 201.36% |
| Sep 30, 2016 | -3.31% |
| Jun 30, 2016 | -48.57% |